Innovative study design and sub-populations are the future of epilepsy drug development

Rare disease drug development involves challenges such as an incomplete understanding of the disease to inform trial design, requirements for more sensitive and specific outcome measures, and difficulties of recruiting a small sample to participate.

Meet the author